Gilead (GILD) says they have reached guidance number for Yeztugo in 2025 of USD 150mln after the launch in the middle of 2025, via JPM Conference
Importance
Level 1
- Filed Anito-cel with FDA, awaiting a confirmation of acceptance letter they expect this quarter, and targeting launch for h2 2026
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#GILEAD SCIENCES INC#GILD.US#JPMORGAN CHASE & CO#FOREX#EQUITIES#METALS#US SESSION#BIOTECHNOLOGY#DIVERSIFIED BANKS#METALS & MINING#BIOTECHNOLOGY (GROUP)#BANKS#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BANKS (GROUP)#S&P 500 INDEX#NASDAQ 100 INDEX#GILD#JPM#DXY#GLOBAL NEWS